Article
Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from southern Italy cancer centers
2026-06-28
Abstract excerpt
<title>Abstract</title> <p>Studies in female Hodgkin lymphoma (HL) survivors have shown that doxorubicin hydrochloride exposure at young adult and adult (YA&A) age is associated with an increased risk of breast cancer (BC) regardless of chest-radiotherapy (c-RT). Although non-pegylated liposomal doxorubicin (NPLD)-based regimens have shown efficacy and safety for lymphoma treatment, the association between NPLD a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2473fd77-1824-511d-a893-f4b72d0def5f
- DOI
- 10.21203/rs.3.rs-10067296/v1
